Nifedipine Versus Atosiban for Threatened Preterm Birth (APOSTEL III): A Multicenter, Randomized Controlled Trial

Elvira O.G. Van Vliet, Tobias A.J. Nijman, Ewoud Schuit, Karst Y. Heida, Brent C. Opmeer, Marjolein Kok, Wilfried Gyselaers, Martina M. Porath, Mallory Woiski, Caroline J. Bax, Kitty W.M. Bloemenkamp, Hubertina C.J. Scheepers, Yves Jacquemyn, Erik Van Beek, Johannes J. Duvekot, Maureen T.M. Franssen, Dimitri N. Papatsonis, Joke H. Kok, Joris A.M. Van Der Post, Arie FranxBen W. Mol, Martijn A. Oudijk

Research output: Contribution to journalComment / DebateOtherpeer-review

Original languageEnglish
Pages (from-to)514-516
Number of pages3
JournalObstetrical and Gynecological Survey
Volume71
Issue number9
DOIs
Publication statusPublished - 1 Sep 2016
Externally publishedYes

Cite this

Van Vliet, E. O. G., Nijman, T. A. J., Schuit, E., Heida, K. Y., Opmeer, B. C., Kok, M., Gyselaers, W., Porath, M. M., Woiski, M., Bax, C. J., Bloemenkamp, K. W. M., Scheepers, H. C. J., Jacquemyn, Y., Van Beek, E., Duvekot, J. J., Franssen, M. T. M., Papatsonis, D. N., Kok, J. H., Van Der Post, J. A. M., ... Oudijk, M. A. (2016). Nifedipine Versus Atosiban for Threatened Preterm Birth (APOSTEL III): A Multicenter, Randomized Controlled Trial. Obstetrical and Gynecological Survey, 71(9), 514-516. https://doi.org/10.1097/01.ogx.0000491261.80068.f8